A world-first study has revealed that two hours of supervised exercise per week significantly benefits people with metastatic breast cancer, improving quality of life while reducing healthcare costs. The PREFERABLE-EFFECT trial, involving 357 participants worldwide, including 35 Australians, is the most extensive exercise study conducted for this population. The study revealed cost-effectiveness benefits of the nine-month supervised exercise program compared to general activity advice. Cost savings were achieved through reductions in home care, day treatments, hospital admissions, and productivity losses. As the number of individuals diagnosed with metastatic breast cancer increases, so too do the associated costs. Investing in supportive care strategies, such as supervised exercise programs, is crucial for managing the cancer burden and mitigating disease- and treatment-related side effects. By demonstrating both clinical and economic benefits, these findings provide a robust foundation for integrating supportive care programs into standard care practices to improve outcomes for patients while reducing the financial burden on healthcare systems. Lead Australian researcher, Melbourne exercise Physiologist Dr. Eva Zopf, emphasised the study’s significance: "These unique findings from our multinational PREFERABLE-EFFECT study are particularly important for healthcare providers, policymakers, and insurers. They demonstrate that supervised exercise for patients with metastatic breast cancer is not only beneficial in improving quality of life and reducing treatment-related side effects but also reduces healthcare costs." BCNA welcomed the findings, emphasising the need to prioritise people living with metastatic breast cancer by better understanding and addressing their needs. Recent data from New South Wales revealed a higher number of people living with metastatic breast cancer than previously estimated, yet they remain underserved in research and healthcare planning. The study underscores the urgent need for national data collection and tailored care to ensure people with metastatic breast cancer can live well with breast cancer. For more information, read our media release at https://ow.ly/ZbIB50UIc9J Eva Zopf Vicki Durston #MetastaticBreastCancer #ExerciseForHealth #CancerResearch #BreastCancerAwareness #SupportiveCare #HealthcareCostSavings #ExerciseBenefits #PatientOutcomes
well done Eva Zopf
Graphic Designer at Australian Medical Association (Victoria)
2moAs a participant in the first ExMed cancer exercise trial in 2018 after my comprehensive breast cancer treatment, I can not emphasis the benefits of exercise for me, in recovery and in continued life. Not only does it benefit the body, but the mind, at a time when finding peace can be hard. I will forever champion exercise. If you are on the side lines, support those who might benefit, to take that step.